UK PM Theresa May proposes £160mn investment into healthcare research sector

By Jonathan Dyble
In the ever-imminent face of Brexit, the UK government has pledged £160mn to the healthcare and medical research sector, part of Prime Minister Theresa...

In the ever-imminent face of Brexit, the UK government has pledged £160mn to the healthcare and medical research sector, part of Prime Minister Theresa May’s plans for a £4.7bn increase in research and development over the next four years.

In the wake of the announcement, the industry is set to benefit from a more favourable tax policy and increased funding amongst a general policy that will encourage sector growth.

The healthcare and medical research industry was identified as one of five key sectors to the UK economy by May, with almost 235,000 employees and 5,000 companies operating in the sector.

See Also:

The first phase of investment, recommended by the UK’s life sciences industry, will see £146mn invested to support the development of advanced treatments and research by industry SME’s, and help cultivate manufacturing innovation.

The remaining £14mn of the £160mn of funding will go to medical technology research centres, with the aim of enhancing collaboration between private research companies and the National Health Service, with the Life Sciences Industrial Strategy report outlining this as a key goal.

“We have created a strategy which capitalises on our strong science base to further build the industry into a globally-unique and internationally competitive life sciences eco-system,” said Sir John Bell, Chairman of the UK Office for Strategic Coordination of Health Research and the man behind the government-commissioned report.

The move is in line with the government’s broader plans of a modern industrial strategy, designed to boost Britain’s weak productivity growth levels.

Share

Featured Articles

Philips Future Health Index Report: AI to Cut Waiting Times

Healthcare technology leader Philips says virtual care and AI is turning in an effort to cope with demand in its Future Health Index Report 2024

HCLTech and Olympus Advance AI into the Healthcare Industry

Giants HCLTech and Olympus Corporation, have developed their partnership to utilise technology and AI to transform the healthcare industry.

Cancer Vaccines Breakthrough a Glimpse of Healthcare Future

As the UK's NHS becomes the first healthcare provider to launch a cancer vaccine testing programme, we explore this groundbreaking oncological treatment

Change Healthcare Cyberattack Fallout Continues

Health Insurance & Finance

McKinsey: National E-health Initiatives on the Rise

Technology & AI

Edwards Lifesciences: a Profile of the Heart Tech Specialist

Medical Devices & Pharma